Ignite Creation Date:
2025-12-24 @ 7:16 PM
Ignite Modification Date:
2026-01-04 @ 12:37 PM
Study NCT ID:
NCT03206203
Status:
COMPLETED
Last Update Posted:
2024-12-12
First Post:
2017-06-26
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Carboplatin With or Without Atezolizumab in Treating Patients With Stage IV Triple Negative Breast Cancer
Sponsor:
Vanderbilt-Ingram Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-08-29
Start Date Type:
ACTUAL
Primary Completion Date:
2022-11-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-10-04
Completion Date Type:
ACTUAL
First Submit Date:
2017-06-26
First Submit QC Date:
None
Study First Post Date:
2017-07-02
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-05-08
Results First Submit QC Date:
None
Results First Post Date:
2023-09-13
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-11-25
Last Update Post Date:
2024-12-12
Last Update Post Date Type:
ACTUAL